Mezey E
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
Semin Liver Dis. 1993 May;13(2):210-6. doi: 10.1055/s-2007-1007350.
The treatment of alcoholic liver disease at present consists of abstinence from alcohol, bed rest, and dietary intake or administration of adequate amounts of calories and protein. Besides corticosteroids, which have been shown to improve hospital survival in severely ill patients with alcoholic hepatitis and liver transplantation in advanced cirrhosis, no successful specific therapy is available for alcoholic liver disease. Potential new therapeutic approaches include: (1) Treatment with specific dietary supplements such as polyunsaturated lecithin, which in baboons prevented the progression of the early stages of pericentral and interstitial fibrosis to septal fibrosis and cirrhosis; (2) antagonists to cytokines or antibodies to cytokine receptors for cytokines that have been shown to enhance hepatocellular necrosis or fibrosis; (3) substances that block pathways of oxygen radical formation or increase their metabolism or binding to form nonharmful compounds; (4) inhibition of collagen synthesis by proline analogues that increase intracellular collagen degradation or increase in collagen degradation by stimulation of collagenase or by insertion of exogenous DNA encoding amino or carboxyterminal peptides of procollagen into hepatocytes; and (5) stimulation of hepatic regeneration and recovery from alcohol-inducer liver injury.
目前,酒精性肝病的治疗包括戒酒、卧床休息以及摄入或给予足够的热量和蛋白质。除了已被证明可提高重症酒精性肝炎患者的住院生存率以及晚期肝硬化患者肝移植成功率的皮质类固醇外,尚无针对酒精性肝病的成功特效疗法。潜在的新治疗方法包括:(1)使用特定的膳食补充剂进行治疗,如多不饱和卵磷脂,在狒狒中它可防止中央周围和间质纤维化早期阶段发展为间隔纤维化和肝硬化;(2)针对已被证明可增强肝细胞坏死或纤维化的细胞因子的细胞因子拮抗剂或细胞因子受体抗体;(3)阻断氧自由基形成途径或增加其代谢或与形成无害化合物结合的物质;(4)通过增加细胞内胶原降解的脯氨酸类似物抑制胶原合成,或通过刺激胶原酶或通过将编码前胶原氨基或羧基末端肽的外源DNA插入肝细胞来增加胶原降解;以及(5)刺激肝脏再生并从酒精诱导的肝损伤中恢复。